TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biopotent AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
424
|
400
|
592 |
| Financial expenses |
4
|
0
|
0 |
| Earnings before taxes |
31
|
42
|
57 |
| EBITDA |
66
|
67
|
81 |
| Total assets |
264
|
321
|
246 |
| Current assets |
159
|
179
|
222 |
| Current liabilities |
89
|
122
|
103 |
| Equity capital |
131
|
131
|
119 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
49.6%
|
40.8%
|
48.4% |
| Turnover per employee |
212
|
200
|
296 |
| Profit as a percentage of turnover |
7.3%
|
10.5%
|
9.6% |
| Return on assets (ROA) |
13.3%
|
13.1%
|
23.2% |
| Current ratio |
178.7%
|
146.7%
|
215.5% |
| Return on equity (ROE) |
23.7%
|
32.1%
|
47.9% |
| Change turnover |
38
|
-194
|
40 |
| Change turnover % |
10%
|
-33%
|
7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.